table of content
Table of Contents
Post-pandemic Era-Global Non-Invasive Cancer Diagnostics Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 CTCs -Product Introduction and Major Company
1.1.2 CTNAS -Product Introduction and Major Company
1.1.3 Exosomes -Product Introduction and Major Company
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Five-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Sales (2018 & 2022 & 2026)
2.2 Regional Market Share in Terms of Revenue (2018 & 2022 & 2026)
2.3 Regional Market Share in Terms of Consumption (2018 & 2022 & 2026)
3 Global Non-Invasive Cancer Diagnostics Market Assessment by Type
3.1 Global Non-Invasive Cancer Diagnostics Sales by Type (2018-2028)
3.2 Global Non-Invasive Cancer Diagnostics Revenue by Type (2018-2028)
3.3 North America Non-Invasive Cancer Diagnostics Sales and Revenue by Type (2018-2028)
3.4 Asia Non-Invasive Cancer Diagnostics Sales and Revenue by Type (2018-2028)
3.5 Europe Non-Invasive Cancer Diagnostics Sales and Revenue by Type (2018-2028)
3.6 Middle East & Africa Non-Invasive Cancer Diagnostics Sales and Revenue by Type (2018-2028)
3.7 South America Non-Invasive Cancer Diagnostics Sales and Revenue by Type (2018-2028)
4 Historical & Forecast Global Non-Invasive Cancer Diagnostics Market Assessment by Application
4.1 Global Non-Invasive Cancer Diagnostics Consumption and Consumption in Different Application Field (2018-2028)
4.2 North America Non-Invasive Cancer Diagnostics Consumption and Consumption in Different Application Field (2018-2028)
4.3 Asia Non-Invasive Cancer Diagnostics Consumption and Consumption in Different Application Field (2018-2028)
4.4 Europe Non-Invasive Cancer Diagnostics Consumption and Consumption in Different Application Field (2018-2028)
4.5 Middle East & Africa Non-Invasive Cancer Diagnostics Consumption and Consumption in Different Application Field (2018-2028)
4.6 South America Non-Invasive Cancer Diagnostics Consumption and Consumption in Different Application Field (2018-2028)
5 North America
5.1 US Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
5.2 Canada Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
5.3 Mexico Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
6 Asia
6.1 China Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
6.2 Japan Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
6.3 India Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
6.4 Korea Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
6.5 Southeat Asia Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
7 Europe
7.1 Germany Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
7.2 UK Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
7.3 France Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
7.4 Russia Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
7.5 Italy Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
8 Middle East and Africa
8.1 Saudi Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
8.2 UAE Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
8.3 Egypt Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
8.4 Nigeria Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
8.5 South Africa Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
9 South America
9.1 Brazil Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
9.2 Argentina Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
9.3 Colombia Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2028)
10 Global Non-Invasive Cancer Diagnostics Average Price Trend
10.1 Market Price for Each Type of Non-Invasive Cancer Diagnostics in North America (2018-2028)
10.2 Market Price for Each Type of Non-Invasive Cancer Diagnostics in Asia (2018-2028)
10.3 Market Price for Each Type of Non-Invasive Cancer Diagnostics in Europe (2018-2028)
10.4 Market Price for Each Type of Non-Invasive Cancer Diagnostics in Middle East & Africa (2018-2028)
10.5 Market Price for Each Type of Non-Invasive Cancer Diagnostics in South America (2018-2028)
11 Value Chain
11.1 Non-Invasive Cancer Diagnostics Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Non-Invasive Cancer Diagnostics Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.2.2 Post-pandemic Era
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Major Players of Global Non-Invasive Cancer Diagnostics Market, Competitive Analysis
12.1 Gen-Probe Inc
12.1.1 Gen-Probe Inc Company Profiles and Company News
12.1.2 Gen-Probe Inc Product Introduction
12.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales, Revenue (2018-2022)
12.1.4 SWOT Analysis
12.2 Digene Corporation
12.2.1 Digene Corporation Company Profiles and Company News
12.2.2 Digene Corporation Product Introduction
12.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Sales, Revenue (2018-2022)
12.2.4 SWOT Analysis
12.3 Quest Diagnostics Inc
12.3.1 Quest Diagnostics Inc Company Profiles and Company News
12.3.2 Quest Diagnostics Inc Product Introduction
12.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales, Revenue (2018-2022)
12.3.4 SWOT Analysis
12.4 Cancer, Genetics Inc
12.4.1 Cancer, Genetics Inc Company Profiles and Company News
12.4.2 Cancer, Genetics Inc Product Introduction
12.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales, Revenue (2018-2022)
12.4.4 SWOT Analysis
12.5 Affymetrix Inc
12.5.1 BIOVIEW Inc Company Profiles and Company News
12.5.2 BIOVIEW Inc Product Introduction
12.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales, Revenue (2018-2022)
12.5.4 SWOT Analysis
12.6 AVIVA Biosciences Corporation
12.6.1 AVIVA Biosciences Corporation Company Profiles and Company News
12.6.2 AVIVA Biosciences Corporation Product Introduction
12.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales, Revenue (2018-2022)
12.6.4 SWOT Analysis
12.7 Laboratory Corporation of America Holdings (LabCorp)
12.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Profiles and Company News
12.7.2 Laboratory Corporation of America Holdings (LabCorp) Product Introduction
12.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales, Revenue (2018-2022)
12.7.4 SWOT Analysis
12.8 A&G Pharmaceutical
12.8.1 A&G Pharmaceutical Company Profiles and Company News
12.8.2 A&G Pharmaceutical Product Introduction
12.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Sales, Revenue (2018-2022)
12.8.4 SWOT Analysis
12.9 Affymetrix Inc
12.9.1 Affymetrix Inc Company Profiles and Company News
12.9.2 Affymetrix Inc Product Introduction
12.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Sales, Revenue (2018-2022)
12.9.4 SWOT Analysis
12.10 Precision Therapeutics
12.10.1 Precision Therapeutics Company Profiles and Company News
12.10.2 Precision Therapeutics Product Introduction
12.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Sales, Revenue (2018-2022)
12.10.4 SWOT Analysis
13 Global Non-Invasive Cancer Diagnostics Market, Competitive Landscape and Market Forecast
13.1 Key Companies Dominating the Global Non-Invasive Cancer Diagnostics Market
13.2 Concentration Ratio (CR5) of Global Non-Invasive Cancer Diagnostics Market (2018)
13.2.1 Market Share of Top 5 Players in Term of Revenue (2018)
13.3 Concentration Ratio (CR5) of Global Non-Invasive Cancer Diagnostics Market (2022)
13.3.1 Market Share of Top 5 Players in Term of Revenue (2022)
14 Conclusion
15 Methodology and Data Source
